Literature DB >> 25443663

Increased risk of ischaemic stroke among patients with multiple sclerosis.

C-H Tseng1, W-S Huang, C-L Lin, Y-J Chang.   

Abstract

BACKGROUND AND
PURPOSE: Inflammatory processes including autoimmune diseases which ignite endothelial dysfunction and atherosclerosis may promote development of cardiovascular diseases including ischaemic stroke. This study aimed to evaluate whether multiple sclerosis (MS) increases stroke risk.
METHODS: A national insurance claim data set of 22 million enrollees in Taiwan was used to identify 1174 patients with MS and 4696 randomly selected age- and gender-matched controls from 1 January 1997 to 31 December 2010. Both cohorts were followed up until the occurrence of stroke or censor. Relevant covariates, such as age, gender, hypertension, diabetes, hyperlipidaemia, coronary artery disease, congestive heart failure and pregnancy, were included for further survey. The hazard ratio (HR) of stroke was assessed using a Cox proportional hazards regression model.
RESULTS: After adjusting for the relevant covariates, the MS cohort had an increased risk of stroke (adjusted HR = 12.1 for 1 year; adjusted HR = 4.69 for 2-5 years) compared with the control cohort within 5 years of follow-up. Amongst participants without comorbidities, the MS cohort was still at a greater stroke risk than the control cohort [HR 4.93, 95% confidence interval (CI) 2.85-8.55]. Moreover, in the population aged ≤40, MS was associated with a significantly increased risk of stroke (HR 12.7, 95% CI 3.44-46.7).
CONCLUSIONS: Multiple sclerosis is declared to be associated with an increased risk in developing stroke, which requires closer attention to this group of patients for stroke prevention, especially in the younger population.
© 2014 EAN.

Entities:  

Keywords:  autoimmune disease; ischaemic stroke; multiple sclerosis

Mesh:

Year:  2014        PMID: 25443663     DOI: 10.1111/ene.12598

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  13 in total

1.  Prevalence of chronic comorbidities in people with multiple sclerosis: descriptive study based on administrative data in Tuscany (Central Italy).

Authors:  Daiana Bezzini; Elisa Gualdani; Matilde Razzanelli; Mario Alberto Battaglia; Rosa Cortese; Paolo Francesconi; Monica Ulivelli
Journal:  Neurol Sci       Date:  2022-08-18       Impact factor: 3.830

2.  Non-infectious comorbidity in patients with multiple sclerosis: A national cohort study in Sweden.

Authors:  Anna Castelo-Branco; Flaminia Chiesa; Camilla E Bengtsson; Sally Lee; Neil N Minton; Steve Niemcryk; Anders Lindholm; Mats Rosenlund; Fredrik Piehl; Scott Montgomery
Journal:  Mult Scler J Exp Transl Clin       Date:  2020-08-14

3.  Markers of oxidative/nitrative damage of plasma proteins correlated with EDSS and BDI scores in patients with secondary progressive multiple sclerosis.

Authors:  Agnieszka Morel; Michał Bijak; Marta Niwald; Elżbieta Miller; Joanna Saluk
Journal:  Redox Rep       Date:  2017-05-19       Impact factor: 4.412

4.  Early recognition of multiple sclerosis using natural language processing of the electronic health record.

Authors:  Herbert S Chase; Lindsey R Mitrani; Gabriel G Lu; Dominick J Fulgieri
Journal:  BMC Med Inform Decis Mak       Date:  2017-02-28       Impact factor: 2.796

5.  Genetic Etiology Shared by Multiple Sclerosis and Ischemic Stroke.

Authors:  Zhu Tian; Yang Song; Yang Yao; Jie Guo; Zhongying Gong; Zhiyun Wang
Journal:  Front Genet       Date:  2020-07-03       Impact factor: 4.599

6.  Physical and functional aspects of persons with multiple sclerosis practicing Tai-Geiko: randomized trial.

Authors:  Viviane Regina Leite Moreno Ultramari; Adriano Percival Calderaro Calvo; Rosilene Andrade Silva Rodrigues; Waléria Christiane Rezende Fett; Jose Urias de Moraes Neto; Almir de França Ferraz; Michelle Jalousie Kommers; Heloise Helena Siqueira Borges; Michell Vetoraci Viana; Monica Cattafesta; Luciane Bresciani Salaroli; Carlos Alexandre Fett
Journal:  Clinics (Sao Paulo)       Date:  2020-01-10       Impact factor: 2.365

7.  Is There an Increased Risk for Ischemic Stroke in Patients with Multiple Sclerosis, and If So, Should Preventive Treatment Be Considered?

Authors:  Steven M LeVine
Journal:  Front Neurol       Date:  2016-08-11       Impact factor: 4.003

8.  Increased Risk of Stroke in Patients With Fibromyalgia: A Population-BASED Cohort Study.

Authors:  Chun-Hung Tseng; Jiunn-Horng Chen; Yu-Chiao Wang; Ming-Chia Lin; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

9.  Subcutaneous Interferon-β1a Does Not Increase the Risk of Stroke in Patients with Multiple Sclerosis: Analysis of Pooled Clinical Trials and Post-Marketing Surveillance.

Authors:  Meritxell Sabidó; Saritha Venkatesh; Brooke Hayward; Julie Aldridge; Alan Gillett
Journal:  Adv Ther       Date:  2018-09-25       Impact factor: 3.845

10.  Increased Pro-Thrombotic Platelet Activity Associated with Thrombin/PAR1-Dependent Pathway Disorder in Patients with Secondary Progressive Multiple Sclerosis.

Authors:  Angela Dziedzic; Elzbieta Miller; Michal Bijak; Lukasz Przyslo; Joanna Saluk-Bijak
Journal:  Int J Mol Sci       Date:  2020-10-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.